Jarry U, Bostoen M, Archambeau J, Pineau R, et al. Afatinib or Bevacizumab in combination with Osimertinib efficiently control tumor development in orthotopic murine models of non-small lung cancer. PLoS One 2024;19:e0304914.
PMID: 38935790